本页面由Tiger Trade Technology Pte. Ltd.提供服务

CymaBay Therapeutics Inc.

32.48
0.0000
成交量:- -
成交额:2.71亿
市值:37.29亿
市盈率:-32.74
高:32.48
开:32.48
低:32.48
收:32.48
52周最高:32.50
52周最低:7.26
股本:1.15亿
流通股本:9,602.60万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9921
每股收益(LYR):-0.9921
净资产收益率:-64.17%
总资产收益率:-22.05%
市净率:12.76
市盈率(LYR):-32.74

数据加载中...

2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/22

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/03/22

重要事件披露

Form 8-K - Current report
2024/03/20

重要事件披露

Form 8-K - Current report
2024/03/16

SEC问询函

Form CORRESP - Correspondence
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]